ArticleVeterinary research communications2026
Ursolic acid methyl ester mitigates aluminum oxide nanoparticle-induced hematobiochemical, immune, and oxidative disturbances and modulates apoptosis-related gene expression in Oreochromis niloticus.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Aluminum oxide nanoparticles (AONPs) represent an emerging toxicological risk to aquatic animals, with potential adverse effects on fish health and productivity. This study assessed the efficiency of ursolic acid methyl ester (UME) in reducing AONPs toxicity in Nile tilapia (Oreochromis niloticus). Three hundred tilapia fish (11.50 ± 0.50 g) were classified into four groups (75 fish per group, five replicates per group, and 15 fish per replicate): control, UME (1.0 mg/L water), AONPs (10 mg/L water), and UME + AONPs groups, with a forty-day exposure duration. A basal diet was fed to all groups. Comprehensive assessments included hepatorenal function, lipid and protein profiles, stress biomarkers, immune responses, antioxidant status, and tissue histomorphology. Hematological parameters were improved by aquas exposure of UME, reversing AONPs-induced anemia, leukopenia, hypoproteinemia, and hyperlipidemia. It also mitigated the elevation of serum levels of glucose, cortisol, liver enzymes, and kidney injury markers as well as hepatic malondialdehyde caused by AONPs. Tissue antioxidant biomarkers (hepatic CAT, SOD, and GPx) and immunological indicators (lysozyme activity, complement factor 3, nitric oxide, phagocytic activity %, and NBT) were both significantly boosted by UME exposure. At the molecular level, UME downregulated apoptosis-related genes (caspase-3 and p53) and upregulated immune- and cytoprotective-related genes (ifn-α, il-10, ho-1, and keap-1). The histological examination of the liver, kidneys, and spleen showed that UME significantly corrected the degenerative alterations brought on by AONPs. These findings advocate that UME is a promising candidate for mitigating AONPs toxicity in O. niloticus.
Indexed as
Identifiers
42053684What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.